Please login to the form below

Not currently logged in

Sanofi to supply flu vaccine to Brazil

Sanofi Pasteur has signed an agreement for the production and supply of a vaccine against the novel A (H1N1) influenza virus

Sanofi Pasteur, the vaccines division of sanofi-aventis, has signed an agreement with Butantan Institute in Brazil for the production and supply of a vaccine against the novel A(H1N1) influenza virus. 

The Brazilian Ministry of Health has ordered an initial supply of 18 million doses of the new A(H1N1) influenza virus vaccine, comprising one million doses in final presentation and 17 million doses in bulk form. The agreement includes an option for an additional 15 million doses of A(H1N1) vaccine, should the World Health Organisation (WHO) request influenza manufacturers to switch production from the regular Southern Hemisphere Seasonal influenza vaccine to the Pandemic A(H1N1) vaccine. 

Wayne Pisano, Sanofi Pasteur's president and chief executive officer, said: "Sanofi Pasteur and Butantan Institute are historical and successful partners who will bring a tailored response to public health needs in the context of pandemic influenza in Brazil. Our goal is to produce and deliver as quickly as possible the pandemic vaccine, which meets the requirements defined by the Brazilian health authorities. We rely on our close collaboration with Butantan Institute to produce and deliver the vaccine."  

The A(H1N1) vaccine antigen bulk will be manufactured in Sanofi Pasteur's facility. Dosage requirements will be determined by clinical trial outcomes. Butantan Institute will make up the A(H1N1) vaccine's final formulation, filling and packaging in its Sao Paolo facility (Brazil). It will also handle distribution. 

Sanofi Pasteur is a leading vaccine manufacturer in Brazil with a portfolio of 20 vaccines. Its involvement in the country dates back to 1974 when it produced and delivered 90 million doses of meningitis vaccine in response to an outbreak of the disease. Since 1999, Sanofi Pasteur has partnered Butantan Institute in the immunisation of Brazil's elderly population against influenza. In 2008, Sanofi Pasteur responded to a yellow fever outbreak in Brazil by delivering four million doses of yellow fever vaccine.

9th September 2009


Featured jobs

Subscribe to our email news alerts


Add my company

We live in a time of participation – patients actively involved in their own care recover faster and live longer....

Latest intelligence

What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....
NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE The bold digital clock featured on the EUGDPR (EU General Data Protection Regulation)1 website indicates – to the second...
Health knowledge: Why is it so important?
Health knowledge plays an important role in population health, but by itself is rarely enough to prompt a change in the behaviours that cause the risks....